Evidence map›Paper›PMID 16856011›Full record

SynthesisThe Cochrane database of systematic reviews2006

Corticosteroids for treating dengue shock syndrome.

R Panpanich, P Sornchai, K Kanjanaratanakorn

Abstract readSystematic Review
PubMed Publisher
In one paragraph

Synthesis in The Cochrane database of systematic reviews, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 3 syntheses or guidelines pooled it, 78 citations in OpenAlex.

  1. Pooled it
  2. Corticosteroids for dengue infection.The Cochrane database of systematic reviews · 2014
    Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Article
  7. ISCCM Position Statement: Management of Severe Dengue in Intensive Care Unit.Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2024
    Article
  8. Review
  9. Article
  10. Neurological Manifestations of Perinatal Dengue.Newborn (Clarksville, Md.) · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Safety and Efficacy of a Single Dose of Anti-D (WinRhoIndian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2017
    Article
  15. Effect of a Dengue Clinical Case Management Course on Physician Practices in Puerto Rico.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2016
    Article
  16. Dengue, Zika and Chikungunya: Emerging Arboviruses in the New World.The western journal of emergency medicine · 2016
    Review
  17. Article
  18. Corticosteroids in Pediatric Shock: A Call to Arms.Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies · 2015
    Article
  19. Case series of fatal Leptospira spp./dengue virus co-infections-Puerto Rico, 2010-2012.The American journal of tropical medicine and hygiene · 2014
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

R PanpanichFaculty of Medicine, Community Medicine, Chiang Mai University, 110 Intawaroros, Chiang Mai, North, Thailand 50200. rpanpani@mail.med.cmu.ac.th
P Sornchai
K Kanjanaratanakorn
Chiang Mai University · THNakornping Hospital · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDengue shock syndrome is the most severe from of dengue haemorrhagic fever, one of the leading causes of death in children. Observational studies have suggested corticosteroids may benefit people with dengue shock syndrome.

objectivesTo compare corticosteroids with placebo or no corticosteroids for treating dengue shock syndrome. SEARCH STRATEGY: We searched the Cochrane Infectious Disease Group Specialized Register (January 2006), CENTRAL (The Cochrane Library 2005, Issue 4), MEDLINE (1966 to January 2006), EMBASE, (1974 to January 2006), LILACS (1982 to January 2006), and reference lists. We also contacted researchers. SELECTION CRITERIA: Randomized and quasi-randomized controlled trials comparing corticosteroids with no corticosteroids or placebo in people diagnosed with dengue shock syndrome. DATA COLLECTION AND ANALYSIS: Two authors independently applied the inclusion criteria, extracted data, and assessed methodological quality. We calculated the relative risk (RR) for dichotomous data and weighted mean difference for continuous data, and presented them with 95% confidence intervals (CI). MAIN

resultsFour trials involving 284 participants met the inclusion criteria. Corticosteroids were no more effective than placebo or no treatment for reducing the number of deaths (RR 0.68, 95% CI 0.42 to 1.11; 284 participants, 4 trials), the need for blood transfusion (RR 1.08, 0.52 to 2.24; 89 participants, 2 trials), or the number of serious complications (convulsions and pulmonary haemorrhage) as reported in one trial (63 participants). AUTHORS'

conclusionsThere is insufficient evidence to justify the use of corticosteroids in managing dengue shock syndrome. As corticosteroids can potentially do harm, clinicians should not use them unless they are participating in a randomized controlled trial comparing corticosteroids with placebo.

Indexed as

Adrenal Cortex HormonesBlood TransfusionHumansRandomized Controlled Trials as TopicSevere DengueAdrenal Cortex Hormones

Identifiers

PMID16856011
OpenAlexW1529579185

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.